Origin, maturation and antigen presenting function of dendritic cells

Current Opinion in Immunology

Volumn 9, Issue 1, 1997, Pages 10-16

  Cella, Marina ^a   Sallusto, Federica ^a   Lanzavecchia, Antonio ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN;

ANTIGEN PRESENTING CELL; CELL MATURATION; DENDRITIC CELL; IMMUNOSTIMULATION; MACROPHAGE; MONOCYTE; REVIEW; T LYMPHOCYTE;

EID: 0031045622     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(97)80153-7     Document Type: Article

References (75)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 9:1991;271-296.
2. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 176:1992;1693-1702.
3. Inaba K, Steinman RM, Pack MW, Aya H, Inaba M, Sudo T, Wolpe S, Schuler G. Identification of proliferating dendritic cell precursors in mouse blood. J Exp Med. 175:1992;1157-1167.
4. Inaba K, Inaba M, Deguchi M, Hagi K, Yasumizu R, Ikehara S, Muramatsu S, Steinman RM. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA. 90:1993;3038-3042.
5. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature. 360:1992;258-261.
6. + hematopoietic progenitors differentiate along two independent DC pathways giving rise to Langerhans cells and DCs related to dermal dendritic cells.
7. Szabolcs P, Avigan D, Gezelter S, Ciocon DH, Moore MA, Steinman RM, Young JW. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood. 87:1996;4520-4530.
8. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 179:1994;1109-1118.
9. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. of special interest J Immunol Methods. 196:1996;137-151 Together with [12,13], this paper describes improved conditions for the generation of DCs from peripheral blood monocytes and provides a detailed phenotypic analysis.
10. Peters JH, Gieseler R, Thiele B, Steinbach F. Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. Immunol Today. 17:1996;273-278.
11. Piemonti L, Bemasconi S, Luini W, Trobonjaca Z, Minty A, Allavena P, Mantovani A. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. Eur Cytokine Netw. 6:1995;245-252.
12. + dendritic cells. of special interest Proc Natl Acad Sci USA. 93:1996;2588-2592 See annotation [9].
13. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. of special interest J Immunol Methods. 196:1996;121-135 See annotation [9].
14. Ardavin C, Wu L, Li CL, Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population. Nature. 362:1993;761-763.
15. + human thymic precursors can be traced by the differential expression of CD44. J Exp Med. 181:1995;475-483.
16. Galy A, Travis M, Cen D, Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity. 3:1995;459-473.
17. Saunders D, Lucas K, Ismaili J, Wu L, Maraskowsky E, Dunn D, Shortman K. Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte-macrophage colony stimulating factor. of special interest J Exp Med. 184:1996;2185-2196 Describes the cytokine requirements for the generation of DCs from lymphoid thymic precursors.
18. + DCs that may be involved in negative regulation of T cell responses.
19. + bone marrow precursors cultured with c-Kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol. 154:1995;5851-5861.
20. + bone marrow. Blood. 86:1995;420-427.
21. + blood progenitors for anti cancer therapy. Exp Hematol. 23:1995;1463-1471.
22. Metcalf D, Shortman K, Vremec D, Mifsud S, Di-Rago L. Effects of excess GM-CSF levels on hematopoiesis and leukemia development in GM-CSF/macs 41 double transgenic mice. Leukemia. 10:1996;713-719.
23. Maraskowsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. of special interest J Exp Med. 184:1996;1953-1962 Shows that Flt3L in vivo can expand different DC populations.
24. Steinman RM, Swanson J. The endocytic activity of dendritic cells [comment]. J Exp Med. 182:1995;283-288.
25. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products [see comments]. J Exp Med. 182:1995;389-400.
26. Stahl PD. The mannose receptor and other macrophage lectins. Curr Opin Immunol. 4:1992;49-52.
27. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 375:1995;151-155.
28. Mudde GC, Hansel TT, Von Reijsen FC, Osterhoff BF, Bruijnzeel-Koomen CA. IgE: an immunoglobulin specialized in antigen capture? [see comments]. Immunol Today. 11:1990;440-443.
29. Bieber T, De La Salle H, Wollemberg A, Hakimi J, Chizzonite R, Ring J, Hanau D, de La Salle C. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (FceRI). J Exp Med. 175:1992;1285-1290.
30. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, Stingl G. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol. 154:1995;6285-6290.
31. Rock KL. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today. 17:1996;131-137.
32. Bevan MJ. Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med. 182:1995;639-641.
33. Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of an antigen by Langerhans cells in vitro. J Exp Med. 178:1993;509-519.
34. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:1995;243-246.
35. Norbury CC, Hewlett LJ, Prescott AR, Shastri N, Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity. 3:1995;783-791.
36. Reis e Sousa C, Germain RN. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med. 182:1995;841-851.
37. Pure E, Inaba K, Crowley MT, Tardelli L, Witmer-Pack MD, Ruberti G, Fathman G, Steinman RM. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain. J Exp Med. 172:1990;1459-1469.
38. Stossel H, Koch F, Kampgen E, Stoger P, Lenz A, Heufler C, Romani N, Schuler G. Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cell. J Exp Med. 172:1990;1471-1482.
39. Kampgen E, Koch N, Koch F, Stoger P, Heufler C, Schuler G, Romani N. Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. Proc Natl Acad Sci USA. 88:1991;3014-3018.
40. Cumberbatch M, Kimber I. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. Immunology. 75:1992;257-263.
41. Roake JA, Rao AS, Morris PJ, Larsen CP, Hankins DF, Austyn JM. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. of special interest J Exp Med. 181:1995;2237-2247 Demonstration that inflammatory stimuli can induce dendritic cell migration out of nonlymphoid tissue.
42. Pinet V, Vergelli M, Martin R, Bakke O, Long EO. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature. 375:1995;603-606.
43. Sallusto F, Nicolo C, De Maria R, Corinti S, Testi R. Ceramide inhibits antigen uptake and presentation by dendritic cells. J Exp Med. 184:1996;2411-2416.
44. Austyn JM. New insights into the mobilization and phagocytic activity of dendritic cells [comment]. J Exp Med. 183:1996;1287-1292.
45. McWilliam AS, Nelson D, Thomas JA, Holt PG. Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med. 179:1994;1331-1336.
46. Matsuno K, Ezaki T, Kudo S, Uehara Y. A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph [see comments]. of special interest J Exp Med. 183:1996;1865-1878 Describes a novel pathway of DC recruitment and migration in the liver.
47. + dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med. 181:1995;1275-1283.
48. Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell. 86:1996;345-348.
49. + dendritic cell population in mouse Peyer's patches. of special interest Eur J Immunol. 26:1996;1801-1806 Together with [50], this delineates a novel pathway of migration of DCs within Peyer's patches.
50. Kelsall BL, Strober W. Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Payer's patch. of special interest J Exp Med. 183:1996;237-247 See annotation [49].
51. Grouard G, Durand I, Filgueira L, Banchereau J, Liu Y-J. Dendritic cells capable of stimulating T cells in germinal centres. of special interest Nature. 384:1996;364-367 First report of DCs in germinal centers.
52. Sozzani S, Sallusto F, Luini W, Zhou D, Piemonti L, Allavena P, Van Damme J, Valitutti S, Lanzavecchia A, Mantovani A. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J Immunol. 155:1995;3292-3295.
53. Tang A, Amagai M, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature. 361:1993;82-85.
54. Herrlich P, Zoler M, Pals ST, Ponta H. CD44 splice variants: metastases meet lymphocytes. Immunol Today. 14:1993;395-399.
55. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, Zimmermann VS, Davoust J, Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. of special interest J Exp Med. 185:1997;317-328 This paper demonstrates cytoskeletal rearrangements and increased motility in murine DCs upon induction of maturation.
56. + T cells. Immunol Rev. 117:1990;213-234.
57. Springer TA. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
58. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds [see comments]. Science. 273:1996;104-106.
59. Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J. Activation of human dendritic cells through CD40 cross-linking. J Exp Med. 180:1994;1263-1272.
60. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10. Eur J Immunol. 25:1995;1943-1950.
61. + T cells. of special interest J Immunol. 154:1995;5071-5079 First report of IL-12 production by DCs.
62. Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. of special interest J Exp Med. 184:1996;747-752 Together with [63], this demonstrates that ligation of CD40 is a powerful and selective stimulus for IL-12 production in DCs.
63. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kampgen E, Romani N, Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. of special interest J Exp Med. 184:1996;741-746 See annotation [62].
64. Caux C, Massacrier C, Vanbervliet B, Barthelemy C, Liu YJ, Banchereau J. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. Int Immunol. 6:1994;1177-1185.
65. Moser M, De Smedt T, Somasse T, Tielemans F, Chentoufi AA, Muraille E, Van Mechelen M, Urbain J, Leo O. Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol. 25:1995;2818-2824.
66. Snijdewint FG, Kalinski P, Wierenga EA, Bos JD, Kapsenberg ML. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J Immunol. 150:1993;5321-5329.
67. Karp CL, Wysocka M, Wahl LM, Ahearn JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE. Mechanism of suppression of cell-mediated immunity by measles virus. Science. 273:1996;228-231.
68. Young JW, Inaba K. Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antihumor immunity [comment]. J Exp Med. 183:1996;7-11.
69. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ildstad ST, Kast MW, Deleo AB, Lotze MT. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. of special interest Nat Med. 1:1995;1297-1302 Together with [70-74] this work reports initial successful attempts to use DCs to generate protective cytotoxic responses against tumors.
70. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity [see comments]. of special interest J Exp Med. 183:1996;283-287 See annotation [69].
71. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines [see comments]. of special interest J Exp Med. 183:1996;87-97 See annotation [69].
72. Paglia P, Chiodoni C, Rodolfo M, Colombo MP. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo [see comments]. of special interest J Exp Med. 183:1996;317-322 See annotation [69].
73. *0201-binding peptides from the Melan-A/MART-1 self antigen. of special interest Eur J Immunol. 26:1996;1683-1689 See annotation [69].
74. Falo LD Jr, aiKovacsovics-Bankowski M, Thompson K, Rock KL. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. of special interest Nat Med. 1:1995;649-653 See annotation [69].
75. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. of special interest J Exp Med. 184:1996;465-472 Describes the use of RNA as a safe way to express antigens in DCs.